| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 骨疏康(元) | - | - | 96,017,718.67 | 187,235,810.39 | 95,390,179.15 |
| 荷丹片(元) | - | - | 57,760,960.14 | 109,019,939.57 | 61,803,565.92 |
| 脑血疏口服液(元) | - | - | 53,797,854.10 | 117,425,938.72 | 71,218,292.04 |
| 心可舒片(元) | - | - | 143,721,605.69 | 405,525,862.79 | 221,092,502.28 |
| 肌肉骨骼系统药物(元) | 99,775,912.64 | 186,279,827.16 | - | - | - |
| 抗病毒类呼吸系统药物(元) | 12,621,484.38 | 22,026,227.87 | - | - | - |
| 生殖泌尿系统药物(元) | 3,444,254.33 | 7,643,824.70 | - | - | - |
| 心脑血管系统药物(元) | 294,230,400.03 | 506,479,752.87 | - | - | - |
| 其他(元) | 15,286,434.40 | 41,363,761.49 | 43,855,537.61 | 90,299,220.25 | 42,804,568.26 |
| 营业成本(元) | |||||
| 骨疏康(元) | - | - | 43,898,552.76 | 90,691,764.05 | 47,583,788.34 |
| 荷丹片(元) | - | - | 10,347,119.96 | 19,806,388.83 | 10,931,352.42 |
| 脑血疏口服液(元) | - | - | 11,337,120.99 | 27,402,959.04 | 16,361,923.10 |
| 心可舒片(元) | - | - | 26,342,599.09 | 54,409,581.57 | 26,473,322.36 |
| 肌肉骨骼系统药物(元) | 42,685,224.64 | 82,392,328.65 | - | - | - |
| 抗病毒类呼吸系统药物(元) | - | 11,322,120.97 | - | - | - |
| 生殖泌尿系统药物(元) | - | 6,575,498.31 | - | - | - |
| 心脑血管系统药物(元) | 51,411,369.47 | 97,388,496.39 | - | - | - |
| 其他(元) | - | 11,842,847.05 | 17,866,598.58 | 40,126,709.77 | 18,635,177.21 |
| 毛利(元) | |||||
| 骨疏康(元) | - | - | 52,119,165.91 | 96,544,046.34 | 47,806,390.81 |
| 荷丹片(元) | - | - | 47,413,840.18 | 89,213,550.74 | 50,872,213.50 |
| 脑血疏口服液(元) | - | - | 42,460,733.11 | 90,022,979.68 | 54,856,368.94 |
| 心可舒片(元) | - | - | 117,379,006.60 | 351,116,281.22 | 194,619,179.92 |
| 肌肉骨骼系统药物(元) | 57,090,688.00 | 103,887,498.51 | - | - | - |
| 抗病毒类呼吸系统药物(元) | - | 10,704,106.90 | - | - | - |
| 生殖泌尿系统药物(元) | - | 1,068,326.39 | - | - | - |
| 心脑血管系统药物(元) | 242,819,030.56 | 409,091,256.48 | - | - | - |
| 其他(元) | - | 29,520,914.44 | 25,988,939.03 | 50,172,510.48 | 24,169,391.05 |
| 毛利率(%) | |||||
| 骨疏康(%) | - | - | 54.28 | 51.56 | 50.12 |
| 荷丹片(%) | - | - | 82.09 | 81.83 | 82.31 |
| 脑血疏口服液(%) | - | - | 78.93 | 76.66 | 77.03 |
| 心可舒片(%) | - | - | 81.67 | 86.58 | 88.03 |
| 肌肉骨骼系统药物(%) | 57.22 | 55.77 | - | - | - |
| 抗病毒类呼吸系统药物(%) | - | 48.60 | - | - | - |
| 生殖泌尿系统药物(%) | - | 13.98 | - | - | - |
| 心脑血管系统药物(%) | 82.53 | 80.77 | - | - | - |
| 其他(%) | - | 71.37 | 59.26 | 55.56 | 56.46 |
| 收入构成(%) | |||||
| 骨疏康(%) | - | - | 24.30 | 20.59 | 19.38 |
| 荷丹片(%) | - | - | 14.62 | 11.99 | 12.55 |
| 脑血疏口服液(%) | - | - | 13.61 | 12.91 | 14.47 |
| 心可舒片(%) | - | - | 36.37 | 44.59 | 44.91 |
| 肌肉骨骼系统药物(%) | 23.46 | 24.39 | - | - | - |
| 抗病毒类呼吸系统药物(%) | 2.97 | 2.88 | - | - | - |
| 生殖泌尿系统药物(%) | 0.81 | 1.00 | - | - | - |
| 心脑血管系统药物(%) | 69.17 | 66.31 | - | - | - |
| 其他(%) | 3.59 | 5.42 | 11.10 | 9.93 | 8.69 |
| 毛利构成(%) | |||||
| 骨疏康(%) | - | - | 18.26 | 14.26 | 12.84 |
| 荷丹片(%) | - | - | 16.62 | 13.18 | 13.66 |
| 脑血疏口服液(%) | - | - | 14.88 | 13.30 | 14.73 |
| 心可舒片(%) | - | - | 41.13 | 51.86 | 52.27 |
| 肌肉骨骼系统药物(%) | 19.04 | 18.74 | - | - | - |
| 抗病毒类呼吸系统药物(%) | 0.00 | 1.93 | - | - | - |
| 生殖泌尿系统药物(%) | 0.00 | 0.19 | - | - | - |
| 心脑血管系统药物(%) | 80.96 | 73.81 | - | - | - |
| 其他(%) | 0.00 | 5.33 | 9.11 | 7.41 | 6.49 |